080720 — Union Korea Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for Union Korea Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	411	-9,322	-11,109	-932	-18,156
Depreciation
Amortisation
Non-Cash Items	8,331	5,047	3,574	1,154	14,041
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-14,471	-1,668	5,224	-9,279	1,588
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-3,255	-2,196	1,915	-5,063	1,362
Capital Expenditures	-16,049	-8,144	-7,268	-3,455	-2,530
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	74.5	-10.7	-805	-72.8	422
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Cash from Investing Activities	-15,974	-8,154	-8,073	-3,528	-2,108
Financing Cash Flow Items	-30	—	—	—	50
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	11,856	6,809	25,241	-6,025	1,338
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-7,387	-3,636	19,101	-14,647	567